Diabetes
The CGM-based service will begin in Q4.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
Glooko will integrate Hedia's technology into its diabetes management platform. It expects to launch in Europe in the fourth quarter this year and the first quarter in 2024.
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
The partnership allows DarioHealth to integrate data from Dexcom's continuous glucose monitors in its chronic-condition management platform.
They will try out wearable technologies to improve health monitoring.
A study published in JAMA Network Open found that increased EHR use among primary care physicians was associated with improved patient A1c levels, hypertension control and breast cancer screening rates.
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
Also: Virtual ketamine therapy company Nue Life Health brings in $23 million in Series A and debt financing, and Source Health launches out of stealth with a $3 million seed.
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.